THERACRYF PLC
TCF | IL
Overview
Corporate Details
- ISIN(s):
- GB00BMVN2C70 (+2 more)
- LEI:
- 213800NO3E6TSTQO8K20
- Country:
- United Kingdom
- Address:
- SUITE 24G13 - BLOCK 24, SK10 4TG NETHER ALDERLEY
- Website:
- https://theracryf.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
TheraCryf plc develops innovative therapeutics for oncology and behavioral brain disorders. Its strategy is to partner with larger pharma companies after generating compelling data. Key assets include SFX-01 and novel compounds targeting brain health.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-04 16:27 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 23.3 KB | |
| 2025-07-17 08:00 |
Regulatory News Service
Manufacturing Scale Up of Lead Ox-1 Programme
|
English | 14.1 KB | |
| 2025-07-09 16:07 |
Declaration of Voting Results & Voting Rights Announcements
Result of AGM
|
English | 12.3 KB | |
| 2025-06-16 17:10 |
Report Publication Announcement
Notice of AGM
|
English | 13.0 KB | |
| 2025-06-10 13:32 |
Investor Presentation
Ox-1 Investor Presentation
|
English | 11.6 KB | |
| 2025-06-03 08:00 |
Earnings Release
Final results for year to 31 March 2025
|
English | 235.9 KB | |
| 2025-05-23 08:14 |
Earnings Release
Notice of Results and Ox-1 presentation
|
English | 12.5 KB | |
| 2025-05-22 13:43 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 52.1 KB | |
| 2025-05-16 14:00 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 23.2 KB | |
| 2025-03-26 08:00 |
Investor Presentation
Investor webinar
|
English | 16.2 KB | |
| 2025-03-19 13:10 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 23.3 KB | |
| 2025-03-17 15:17 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 52.1 KB | |
| 2025-03-17 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 52.3 KB | |
| 2025-03-13 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 24.0 KB | |
| 2025-03-12 15:03 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 23.7 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
| Ananda Pharma Plc | United Kingdom | N/A | ||
|
AnGes, Inc. | Japan | 4563 |